I certainly don't understand much of the report but the way the radiation doctor described it the one they radiated has shrank by .1 cm in one dimension and grew .4 cm in both the other dimensions. But he thinks that is probably due to the dead cells being smooshed. The other two that were not treated have pretty much disappeared. I'm really suprised about the untreated ones because one of those was just about .5 cm smaller than the one they treated and was also pushing on the dura. Sooo whohoo again for Keytruda. I got my 11th dose Tuesday with radiation the day before and after so maybe that radiation/immunotherapy synergy will happen for me someday or maybe that's why those are gone I dunno cause I got my pd1 within 26 hours of my last head and lower spine radiation too.
I think I've developed clostrophobia though. I was in the same MRI machine as August but this time I kept choking. I also couldn't stand being in that small space this time. I'm not a big guy and I just barely fit. I was also very hot and by the time it was all over my face was really red. A few times I thought I was going to suffocate in there especially with the choking. I think next time I'll request the big donut. Dunno if that will be better but maybe.
I know we all experience scanxiety and this scan almost drove me crazy. I was able to put it out of my mind pretty much until two days before. Then all the fears hit hard imagining the crazy stuff they could find.
Here's the report. I thought it was very thorough and a well done report. They plan to scan again in 3 months. Last week my Mayo doc called to see how I was doing. He had me send my 11/3 pet/ct so I'll send him this too. It really amazes me how much the Mayo docs care.
Take care all my fellow warriors.
Artie
Findings: On the prior precontrast T1 sagittal images the right paracentral posterior parietal osseous lesion measured about 2.3 cm AP x 2.8 cm craniocaudal. On that study on the postcontrast axial images the mass measured 3.6cm transverse. There is now T1 shortening within the soft tissue components of the lesion both within the cranial vault and within the scalp. This may represent products of hemorrhage in ths individual with melanoma. On the study today I measure it at about 3.2 cm craniocaudal x 2.7 cm AP on the precontrast sagittal images. This does appear to have increased in size. When I measure the transverse dimension on the postcontrast axial images I measured about 3.5cm slightly smaller. There is some susceptibility associated with the lesion. This was also present previously. On the axial images the lesion does appear more discrete than on the prior study. There is destruction of the bone with extension of the mass into the cranial vault and into the scalp.
The lesion is again seen to displace and abut the superior sagittal sinus. The sinus continues to enhance without evidence of adjacent thrombosis.
There were additional osseous lesions in the left frontal and left parietal bone on the prior study. These have improved significantly. There has been virtual resolution. No new areas of FLAIR signal alteration are seen within the calvarium. The cerebellar tonsils are normal in position. The corpus callosum is intact. No discrete area of abnormal signal enhancement is seen in the brain parenchyma. The right calvarial lesion which extends into the cranial vault certainly may involve the dura. The dural venous sinuses enhance.
The ventricles are normal in size. Signal voids are present in the vessels.
Impression:
1 Some increase in the craniocaudal and AP dimensions of the mass as measured on the T1 sagittal images and compared to the prior study from 8/21/2014. Some T1 shortening within the soft tissue components which may represent products of hemorrhage in this individual with melanoma. Of note, the transverse dimensions decreased slightly and the lesion appears slightly more circumscribed on the transaxial images. Continued follow-up is recommended.
2. Virtual resolution of the smaller calvarial lesions seen previously.
.
